These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28487159)

  • 1. Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands.
    van den Bogert CA; Souverein PC; Brekelmans CTM; Janssen SWJ; Koëter GH; Leufkens HGM; Bouter LM
    J Clin Epidemiol; 2017 Aug; 88():140-147. PubMed ID: 28487159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules.
    Stegert M; Kasenda B; von Elm E; You JJ; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Briel M;
    J Clin Epidemiol; 2016 Jan; 69():152-60. PubMed ID: 26361993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General characteristics and reasons for the discontinuation of drug clinical trials in mainland China.
    Huo BN; Ai ML; Jia YT; Liu Y; Wang Y; Yin NG; Song L
    BMC Med Res Methodol; 2021 Nov; 21(1):246. PubMed ID: 34773983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort Study.
    Schandelmaier S; Tomonaga Y; Bassler D; Meerpohl JJ; von Elm E; You JJ; Bluemle A; Lamontagne F; Saccilotto R; Amstutz A; Bengough T; Stegert M; Olu KK; Tikkinen KAO; Neumann I; Carrasco-Labra A; Faulhaber M; Mulla SM; Mertz D; Akl EA; Sun X; Busse JW; Ferreira-González I; Nordmann A; Gloy V; Raatz H; Moja L; Rosenthal R; Ebrahim S; Vandvik PO; Johnston BC; Walter MA; Burnand B; Schwenkglenks M; Hemkens LG; Guyatt G; Bucher HC; Kasenda B; Briel M
    J Pediatr; 2017 May; 184():209-214.e1. PubMed ID: 28410086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues in clinical trial design: stopping a trial early and the large and simple trial.
    Thom EA; Klebanoff MA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):619-25. PubMed ID: 16150252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premature trial discontinuation often not accurately reflected in registries: comparison of registry records with publications.
    Alturki R; Schandelmaier S; Olu KK; von Niederhäusern B; Agarwal A; Frei R; Bhatnagar N; Hooft L; von Elm E; Briel M
    J Clin Epidemiol; 2017 Jan; 81():56-63. PubMed ID: 27614277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort Study.
    Schandelmaier S; von Elm E; You JJ; Blümle A; Tomonaga Y; Lamontagne F; Saccilotto R; Amstutz A; Bengough T; Meerpohl JJ; Stegert M; Olu KK; Tikkinen KA; Neumann I; Carrasco-Labra A; Faulhaber M; Mulla SM; Mertz D; Akl EA; Sun X; Bassler D; Busse JW; Ferreira-González I; Nordmann A; Gloy V; Raatz H; Moja L; Rosenthal R; Ebrahim S; Vandvik PO; Johnston BC; Walter MA; Burnand B; Schwenkglenks M; Hemkens LG; Cook DJ; Meade MO; Bucher HC; Kasenda B; Briel M
    Crit Care Med; 2016 Jan; 44(1):130-7. PubMed ID: 26468895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of surgical versus nonsurgical clinical trials: an analysis of 88,498 trials.
    Mouw TJ; Hong SW; Sarwar S; Fondaw AE; Walling AD; Al-Kasspooles M; DiPasco PJ
    J Surg Res; 2018 Jul; 227():151-157. PubMed ID: 29804847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic survey of randomised trials that stopped early for reasons of futility.
    Walter SD; Han H; Guyatt GH; Bassler D; Bhatnagar N; Gloy V; Schandelmaier S; Briel M
    BMC Med Res Methodol; 2020 Jan; 20(1):10. PubMed ID: 31948397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stopping guidelines for an effectiveness trial: what should the protocol specify?
    Tyson JE; Pedroza C; Wallace D; D'Angio C; Bell EF; Das A
    Trials; 2016 May; 17(1):240. PubMed ID: 27165260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
    Walter SD; Han H; Briel M; Guyatt GH
    Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of futility monitoring guidelines using completed phase III oncology trials.
    Zhang Q; Freidlin B; Korn EL; Halabi S; Mandrekar S; Dignam JJ
    Clin Trials; 2017 Feb; 14(1):48-58. PubMed ID: 27590208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data monitoring committees, interim analysis and early termination in paediatric trials.
    Fernandes RM; van der Lee JH; Offringa M
    Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Learning from failure--rationale and design for a study about discontinuation of randomized trials (DISCO study).
    Kasenda B; von Elm EB; You J; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Meerpohl J; Stegert M; Tikkinen KA; Neumann I; Carrasco-Labra A; Faulhaber M; Mulla S; Mertz D; Akl EA; Bassler D; Busse JW; Ferreira-González I; Lamontagne F; Nordmann A; Rosenthal R; Schandelmaier S; Sun X; Vandvik PO; Johnston BC; Walter MA; Burnand B; Schwenkglenks M; Bucher HC; Guyatt GH; Briel M
    BMC Med Res Methodol; 2012 Aug; 12():131. PubMed ID: 22928744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and determinants of selective reporting of clinical drug trials: design of an inception cohort study.
    van den Bogert CA; Souverein PC; Brekelmans CT; Janssen SW; van Hunnik M; Koëter GH; Leufkens HG; Bouter LM
    BMJ Open; 2015 Jul; 5(7):e007827. PubMed ID: 26152325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, characteristics, and publication of discontinued randomized trials.
    Kasenda B; von Elm E; You J; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Meerpohl JJ; Stegert M; Tikkinen KA; Neumann I; Carrasco-Labra A; Faulhaber M; Mulla SM; Mertz D; Akl EA; Bassler D; Busse JW; Ferreira-González I; Lamontagne F; Nordmann A; Gloy V; Raatz H; Moja L; Rosenthal R; Ebrahim S; Schandelmaier S; Xin S; Vandvik PO; Johnston BC; Walter MA; Burnand B; Schwenkglenks M; Hemkens LG; Bucher HC; Guyatt GH; Briel M
    JAMA; 2014 Mar; 311(10):1045-51. PubMed ID: 24618966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of Discontinuation and Nonpublication of Head and Neck Cancer Randomized Clinical Trials.
    Johnson AL; Fladie I; Anderson JM; Lewis DM; Mons BR; Vassar M
    JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):176-182. PubMed ID: 31876933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of discontinued trials suggested that most reasons for recruitment failure were preventable.
    Briel M; Olu KK; von Elm E; Kasenda B; Alturki R; Agarwal A; Bhatnagar N; Schandelmaier S
    J Clin Epidemiol; 2016 Dec; 80():8-15. PubMed ID: 27498376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the Data and Safety Monitoring Board in a clinical trial: the CRISIS study.
    Holubkov R; Casper TC; Dean JM; Anand KJ; Zimmerman J; Meert KL; Newth CJ; Berger J; Harrison R; Willson DF; Nicholson C;
    Pediatr Crit Care Med; 2013 May; 14(4):374-83. PubMed ID: 23392377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.